mifepristone has been researched along with Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parthasarathy, S; Penumetcha, M; Santanam, N; Speisky, H | 1 |
| Haber, E; Harder, JA; Lee, ME; Lee, WS; Yoshizumi, M | 1 |
2 other study(ies) available for mifepristone and Arteriosclerosis
| Article | Year |
|---|---|
A novel alkaloid antioxidant, Boldine and synthetic antioxidant, reduced form of RU486, inhibit the oxidation of LDL in-vitro and atherosclerosis in vivo in LDLR(-/-) mice.
Topics: Analysis of Variance; Animals; Antioxidants; Aporphines; Arteriosclerosis; Diet, Atherogenic; Disease Models, Animal; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Mifepristone; Oxidation-Reduction; Probability; Reference Values; Sensitivity and Specificity | 2004 |
Progesterone inhibits arterial smooth muscle cell proliferation.
Topics: Animals; Arteries; Arteriosclerosis; Cell Division; Cells, Cultured; Cyclins; DNA; Down-Regulation; Female; Humans; Male; Mifepristone; Muscle, Smooth, Vascular; Progesterone; Rats; Receptors, Progesterone; RNA, Messenger | 1997 |